APA

Hida T., Dahlberg S. E., Lydon C. A., Hatabu H., Johnson B. E., Awad M. M. & Nishino M. (20201214). Tumor Volume Analysis as a Predictive Marker for Prolonged Survival in Anaplastic Lymphoma Kinase-rearranged Advanced Non-Small Cell Lung Cancer Patients Treated With Crizotinib. : Journal of thoracic imaging.

Chicago

Hida Tomoyuki, Dahlberg Suzanne E, Lydon Christine A, Hatabu Hiroto, Johnson Bruce E, Awad Mark M and Nishino Mizuki. 20201214. Tumor Volume Analysis as a Predictive Marker for Prolonged Survival in Anaplastic Lymphoma Kinase-rearranged Advanced Non-Small Cell Lung Cancer Patients Treated With Crizotinib. : Journal of thoracic imaging.

Harvard

Hida T., Dahlberg S. E., Lydon C. A., Hatabu H., Johnson B. E., Awad M. M. and Nishino M. (20201214). Tumor Volume Analysis as a Predictive Marker for Prolonged Survival in Anaplastic Lymphoma Kinase-rearranged Advanced Non-Small Cell Lung Cancer Patients Treated With Crizotinib. : Journal of thoracic imaging.

MLA

Hida Tomoyuki, Dahlberg Suzanne E, Lydon Christine A, Hatabu Hiroto, Johnson Bruce E, Awad Mark M and Nishino Mizuki. Tumor Volume Analysis as a Predictive Marker for Prolonged Survival in Anaplastic Lymphoma Kinase-rearranged Advanced Non-Small Cell Lung Cancer Patients Treated With Crizotinib. : Journal of thoracic imaging. 20201214.